Comparing the quantity and quality of randomised placebo-controlled trials of antibiotics for acute respiratory, urinary, and skin and soft tissue infections: a scoping review

Background: The management of acute respiratory infections (ARIs), urinary tract infections (UTIs), and skin and soft tissue infections (SSTIs) should be guided by high quality evidence. Aim: To compare the quantity and quality of randomised placebo-controlled trials of antibiotics for ARIs, UTIs, a...

Full description

Bibliographic Details
Main Authors: Mina Bakhit, Tammy Hoffmann, Miriam Santer, Matthew Ridd, Nick Francis, Eva Hummers, Justin Clark, Carmen Hilliges, Chris Del Mar
Format: Article
Language:English
Published: Royal College of General Practitioners 2020-09-01
Series:BJGP Open
Subjects:
Online Access:https://bjgpopen.org/content/4/4/bjgpopen20X101082
_version_ 1818326029141278720
author Mina Bakhit
Tammy Hoffmann
Miriam Santer
Matthew Ridd
Nick Francis
Eva Hummers
Justin Clark
Carmen Hilliges
Chris Del Mar
author_facet Mina Bakhit
Tammy Hoffmann
Miriam Santer
Matthew Ridd
Nick Francis
Eva Hummers
Justin Clark
Carmen Hilliges
Chris Del Mar
author_sort Mina Bakhit
collection DOAJ
description Background: The management of acute respiratory infections (ARIs), urinary tract infections (UTIs), and skin and soft tissue infections (SSTIs) should be guided by high quality evidence. Aim: To compare the quantity and quality of randomised placebo-controlled trials of antibiotics for ARIs, UTIs, and SSTIs. Design & setting: A scoping review of the literature was performed using comprehensive search strategies. Method: PubMed and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched for published studies from inception until 17 April 2019. Randomised controlled trials (RCTs) that compared participants in primary care or in the community who had uncomplicated acute ARI, UTI, or studies, and were randomised to antibiotic or placebo (or no active treatment), were eligible for inclusion. Two groups of researchers independently screened articles for inclusion, extracted data, and assessed the quality of included studies. Results: A total of 108 eligible studies were identified: 80 on ARI, eight on UTI, and 20 on SSTI. The quality of studies varied with unclear risk of bias (RoB) prevalent in many domains. There was a gradual improvement in the quality of trials investigating ARIs over time, which could not be assessed in SSTI and UTI studies. Conclusion: This review highlights a sparsity of trials assessing the effectiveness of antibiotics in people with UTIs and SSTIs, compared to trials targeting ARIs. This gap in the evidence needs to be addressed by conducting further high quality trials on the effects of antibiotics in patients with UTI and SSTI.
first_indexed 2024-12-13T11:53:52Z
format Article
id doaj.art-73578114a0724b0a92ea6e3defa5ce2c
institution Directory Open Access Journal
issn 2398-3795
language English
last_indexed 2024-12-13T11:53:52Z
publishDate 2020-09-01
publisher Royal College of General Practitioners
record_format Article
series BJGP Open
spelling doaj.art-73578114a0724b0a92ea6e3defa5ce2c2022-12-21T23:47:16ZengRoyal College of General PractitionersBJGP Open2398-37952020-09-014410.3399/bjgpopen20X101082Comparing the quantity and quality of randomised placebo-controlled trials of antibiotics for acute respiratory, urinary, and skin and soft tissue infections: a scoping reviewMina Bakhit0Tammy Hoffmann1Miriam Santer2Matthew Ridd3Nick Francis4Eva Hummers5Justin Clark6Carmen Hilliges7Chris Del Mar8Institute for Evidence-Based Healthcare, Bond University, Gold Coast, Queensland, AustraliaInstitute for Evidence-Based Healthcare, Bond University, Gold Coast, Queensland, AustraliaPrimary Care, Population Sciences and Medical Education, University of Southampton, Southampton, UKPopulation Health Sciences, University of Bristol, Bristol, UKPrimary Care, Population Sciences and Medical Education, University of Southampton, Southampton, UKDepartment of General Practice, Göttingen University Medical Centre, Göttingen, GermanyInstitute for Evidence-Based Healthcare, Bond University, Gold Coast, Queensland, AustraliaDepartment of General Practice, Göttingen University Medical Centre, Göttingen, GermanyInstitute for Evidence-Based Healthcare, Bond University, Gold Coast, Queensland, AustraliaBackground: The management of acute respiratory infections (ARIs), urinary tract infections (UTIs), and skin and soft tissue infections (SSTIs) should be guided by high quality evidence. Aim: To compare the quantity and quality of randomised placebo-controlled trials of antibiotics for ARIs, UTIs, and SSTIs. Design & setting: A scoping review of the literature was performed using comprehensive search strategies. Method: PubMed and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched for published studies from inception until 17 April 2019. Randomised controlled trials (RCTs) that compared participants in primary care or in the community who had uncomplicated acute ARI, UTI, or studies, and were randomised to antibiotic or placebo (or no active treatment), were eligible for inclusion. Two groups of researchers independently screened articles for inclusion, extracted data, and assessed the quality of included studies. Results: A total of 108 eligible studies were identified: 80 on ARI, eight on UTI, and 20 on SSTI. The quality of studies varied with unclear risk of bias (RoB) prevalent in many domains. There was a gradual improvement in the quality of trials investigating ARIs over time, which could not be assessed in SSTI and UTI studies. Conclusion: This review highlights a sparsity of trials assessing the effectiveness of antibiotics in people with UTIs and SSTIs, compared to trials targeting ARIs. This gap in the evidence needs to be addressed by conducting further high quality trials on the effects of antibiotics in patients with UTI and SSTI.https://bjgpopen.org/content/4/4/bjgpopen20X101082anti-bacterial agentprimary health carerespiratory tract infectionsurinary tract infectionsskin and soft tissues infectionsrandomised controlled trials
spellingShingle Mina Bakhit
Tammy Hoffmann
Miriam Santer
Matthew Ridd
Nick Francis
Eva Hummers
Justin Clark
Carmen Hilliges
Chris Del Mar
Comparing the quantity and quality of randomised placebo-controlled trials of antibiotics for acute respiratory, urinary, and skin and soft tissue infections: a scoping review
BJGP Open
anti-bacterial agent
primary health care
respiratory tract infections
urinary tract infections
skin and soft tissues infections
randomised controlled trials
title Comparing the quantity and quality of randomised placebo-controlled trials of antibiotics for acute respiratory, urinary, and skin and soft tissue infections: a scoping review
title_full Comparing the quantity and quality of randomised placebo-controlled trials of antibiotics for acute respiratory, urinary, and skin and soft tissue infections: a scoping review
title_fullStr Comparing the quantity and quality of randomised placebo-controlled trials of antibiotics for acute respiratory, urinary, and skin and soft tissue infections: a scoping review
title_full_unstemmed Comparing the quantity and quality of randomised placebo-controlled trials of antibiotics for acute respiratory, urinary, and skin and soft tissue infections: a scoping review
title_short Comparing the quantity and quality of randomised placebo-controlled trials of antibiotics for acute respiratory, urinary, and skin and soft tissue infections: a scoping review
title_sort comparing the quantity and quality of randomised placebo controlled trials of antibiotics for acute respiratory urinary and skin and soft tissue infections a scoping review
topic anti-bacterial agent
primary health care
respiratory tract infections
urinary tract infections
skin and soft tissues infections
randomised controlled trials
url https://bjgpopen.org/content/4/4/bjgpopen20X101082
work_keys_str_mv AT minabakhit comparingthequantityandqualityofrandomisedplacebocontrolledtrialsofantibioticsforacuterespiratoryurinaryandskinandsofttissueinfectionsascopingreview
AT tammyhoffmann comparingthequantityandqualityofrandomisedplacebocontrolledtrialsofantibioticsforacuterespiratoryurinaryandskinandsofttissueinfectionsascopingreview
AT miriamsanter comparingthequantityandqualityofrandomisedplacebocontrolledtrialsofantibioticsforacuterespiratoryurinaryandskinandsofttissueinfectionsascopingreview
AT matthewridd comparingthequantityandqualityofrandomisedplacebocontrolledtrialsofantibioticsforacuterespiratoryurinaryandskinandsofttissueinfectionsascopingreview
AT nickfrancis comparingthequantityandqualityofrandomisedplacebocontrolledtrialsofantibioticsforacuterespiratoryurinaryandskinandsofttissueinfectionsascopingreview
AT evahummers comparingthequantityandqualityofrandomisedplacebocontrolledtrialsofantibioticsforacuterespiratoryurinaryandskinandsofttissueinfectionsascopingreview
AT justinclark comparingthequantityandqualityofrandomisedplacebocontrolledtrialsofantibioticsforacuterespiratoryurinaryandskinandsofttissueinfectionsascopingreview
AT carmenhilliges comparingthequantityandqualityofrandomisedplacebocontrolledtrialsofantibioticsforacuterespiratoryurinaryandskinandsofttissueinfectionsascopingreview
AT chrisdelmar comparingthequantityandqualityofrandomisedplacebocontrolledtrialsofantibioticsforacuterespiratoryurinaryandskinandsofttissueinfectionsascopingreview